Emergent BioSolutions
EBS
#6766
Rank
S$0.82 B
Marketcap
S$15.42
Share price
-1.24%
Change (1 day)
25.91%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): S$0.21 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are S$0.75 Billion. In 2024 the company made an earning of -S$93.18 Million, an increase over its 2023 earnings that were of -S$0.84 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.21 B-334.1%
2024 -S$93.18 Million-88.82%
2023 -S$0.84 Billion242.73%
2022 -S$0.25 Billion-153.8%
2021 S$0.45 B-20.43%
2020 S$0.56 B278.02%
2019 S$0.15 B27.11%
2018 S$0.11 B-27.12%
2017 S$0.16 B17.21%
2016 S$0.13 B0.45%
2015 S$0.13 B73.51%
2014 S$79.44 M41.36%
2013 S$56.19 M35.2%
2012 S$41.56 M0.4%
2011 S$41.4 M-56.46%
2010 S$95.08 M76.73%
2009 S$53.8 M32.94%
2008 S$40.47 M-5.62%
2007 S$42.88 M
2005 S$62.08 M269.89%
2004 S$16.78 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
S$29.92 B 13,868.54%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
S$0.11 B-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$12.08 B 5,539.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-S$0.34 Billion-255.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.35 B 7,069.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.29 B 971.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
-S$16.03 Million-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA